ArticleLeukemia & lymphoma2017

Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies.

Davis M Seelig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.